Ibogaine by David Dardashti Takes Center Stage on Day One of Psychedelic Science Conference 2025, Emphasizing Collaboration, Education, and Industry Synergy

DENVER, CO – June 19, 2025 – Ibogaine by David Dardashti, a leading initiative in ibogaine research and advocacy, today commenced its participation in the highly anticipated Psychedelic Science Conference 2025 in Denver, Colorado. As the conference officially began its main programming today, June 18th, the presence of Ibogaine by David Dardashti marks a pivotal moment ...

Continue Reading →
Blood vessels surround a brain.

Ambio ibogaine program treats Parkinson’s, other diseases

A new clinical program will use ibogaine, a naturally occurring psychedelic, to treat neurodegenerative conditions including Parkinson’s disease.

Ambio Life Sciences, which hosts other ibogaine programming and participates in scientific research about the drug, soft-launched the program in February. It is the first of its kind in the world, according to the company. People with Parkinson’s,

Continue Reading →
Page 55 of 138 «...3040505354555657...»
UA-77446339-1